These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29766457)

  • 1. Influence of age on variation in patterns of care in patients with rectal cancer in Catalonia (Spain).
    Vernet R; Borras JM; Aliste L; Antonio M; Guarga A; Manchon-Walsh P
    Clin Transl Oncol; 2018 Dec; 20(12):1538-1547. PubMed ID: 29766457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action.
    Manchon-Walsh P; Borras JM; Espinas JA; Aliste L;
    Eur J Surg Oncol; 2011 Apr; 37(4):325-33. PubMed ID: 21296543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.
    Manchon-Walsh P; Aliste L; Espinàs JA; Prades J; Guarga A; Balart J; Biondo S; Castells A; Sanjuan X; Tabernero J; Borras JM;
    Eur J Surg Oncol; 2016 Dec; 42(12):1873-1880. PubMed ID: 27624916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related guideline adherence and outcome in low rectal cancer.
    Schiphorst AH; Verweij NM; Pronk A; Hamaker ME
    Dis Colon Rectum; 2014 Aug; 57(8):967-75. PubMed ID: 25003291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
    Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
    Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
    Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography.
    Monson JR; Probst CP; Wexner SD; Remzi FH; Fleshman JW; Garcia-Aguilar J; Chang GJ; Dietz DW;
    Ann Surg; 2014 Oct; 260(4):625-31; discussion 631-2. PubMed ID: 25203879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Surveillance Patterns after Chemoradiation-Only Compared with Conventional Management for Older Patients with Rectal Cancer.
    Ellis CT; Cole AL; Sanoff HK; Hinton S; Dusetzina SB; Stitzenberg KB
    J Am Coll Surg; 2019 May; 228(5):782-791.e2. PubMed ID: 30685478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
    Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
    Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.
    Lim DR; Bae SU; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    Surg Endosc; 2017 Apr; 31(4):1728-1737. PubMed ID: 27631313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study.
    Schroen AT; Cress RD
    Ann Surg; 2001 Nov; 234(5):641-51. PubMed ID: 11685027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.
    Bhangu A; Kiran RP; Audisio R; Tekkis P
    Eur J Surg Oncol; 2014 Nov; 40(11):1510-6. PubMed ID: 24704032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Center Volume and Type Impact Stage-Specific Utilization of Neoadjuvant Therapy in Rectal Cancer.
    Midura EF; Jung AD; Daly MC; Hanseman DJ; Davis BR; Shah SA; Paquette IM
    Dig Dis Sci; 2017 Aug; 62(8):1906-1912. PubMed ID: 28501970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer?
    Molinari C; Passardi A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1317-1319. PubMed ID: 27754713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.